Literature DB >> 31828452

A mucinous adenocarcinoma of the lip with elevated serum carcinoembryonic antigen levels: a case report.

Takayuki Aoki1, Yusuke Kondo2, Kazunari Karakida3, Hiroyuki Naito4, Hiroshi Kajiwara2, Yoshihide Ota5.   

Abstract

BACKGROUND: Mucinous adenocarcinoma (MAC) rarely occurs in the salivary glands, especially in the labial gland. MACs arising from the salivary glands are characterized by an aggressive behavior due to high invasiveness and a high rate of regional lymph node metastasis. CASE
PRESENTATION: Here, we report a case of MAC arising from the lower lip, shown to have elevated serum carcinoembryonic antigen (CEA) levels by the medical checkup. The tumor showed aggressive behavior and serum CEA levels increased with repeated recurrence. CEA has been shown to have surprisingly diverse functions in cell adhesion, intracellular and intercellular signaling, and complex biological processes such as cancer progression, inflammation, angiogenesis, and metastasis. A MAC arising from the salivary glands may have a poor prognosis because CEA is highly expressed.
CONCLUSIONS: Generally, serum CEA levels have not been used as tumor markers for salivary gland malignancies; however, it may be useful for MAC arising from salivary glands. We recommend prospective research to determine whether serum CEA estimation is useful as a component of routine pre-treatment workup for MACs arising from the salivary glands.

Entities:  

Keywords:  Carcinoembryonic antigen; Lip; Mucinous adenocarcinoma; Salivary gland; Tumor marker

Mesh:

Substances:

Year:  2019        PMID: 31828452     DOI: 10.1007/s10006-019-00818-6

Source DB:  PubMed          Journal:  Oral Maxillofac Surg        ISSN: 1865-1550


  17 in total

1.  Redefined nomenclature for members of the carcinoembryonic antigen family.

Authors:  N Beauchemin; P Draber; G Dveksler; P Gold; S Gray-Owen; F Grunert; S Hammarström; K V Holmes; A Karlsson; M Kuroki; S H Lin; L Lucka; S M Najjar; M Neumaier; B Obrink; J E Shively; K M Skubitz; C P Stanners; P Thomas; J A Thompson; M Virji; S von Kleist; C Wagener; S Watt; W Zimmermann
Journal:  Exp Cell Res       Date:  1999-11-01       Impact factor: 3.905

Review 2.  Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?

Authors:  M J Duffy
Journal:  Clin Chem       Date:  2001-04       Impact factor: 8.327

3.  Intra-oral minor salivary gland tumors: a clinicopathological study of 546 cases.

Authors:  Fábio Ramôa Pires; Gordon A Pringle; Oslei Paes de Almeida; Sow-Yeh Chen
Journal:  Oral Oncol       Date:  2006-09-18       Impact factor: 5.337

Review 4.  Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis.

Authors:  Nicole Beauchemin; Azadeh Arabzadeh
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

Review 5.  Carcinoembryonic antigen (CEA)-based cancer vaccines: recent patents and antitumor effects from experimental models to clinical trials.

Authors:  Mario Turriziani; Massimo Fantini; Monica Benvenuto; Valerio Izzi; Laura Masuelli; Pamela Sacchetti; Andrea Modesti; Roberto Bei
Journal:  Recent Pat Anticancer Drug Discov       Date:  2012-09       Impact factor: 4.169

6.  Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese population.

Authors:  Z Tian; L Li; L Wang; Y Hu; J Li
Journal:  Int J Oral Maxillofac Surg       Date:  2009-11-29       Impact factor: 2.789

7.  Primary mucinous adenocarcinoma of renal pelvis with carcinoembryonic antigen production.

Authors:  Chen-Hsun Ho; Wei-Chou Lin; Yeong-Shiau Pu; Hong-Jeng Yu; Chao-Yuan Huang
Journal:  Urology       Date:  2008-02-21       Impact factor: 2.649

8.  Gene organization of the pregnancy-specific glycoprotein region on human chromosome 19: assembly and analysis of a 700-kb cosmid contig spanning the region.

Authors:  A Olsen; S Teglund; D Nelson; L Gordon; A Copeland; A Georgescu; A Carrano; S Hammarström
Journal:  Genomics       Date:  1994-10       Impact factor: 5.736

9.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

10.  Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma.

Authors:  Fei Sun; Pengcheng Wang; Yiming Zheng; Weiguang Jia; Fuxing Liu; Wei Xiao; Jingjing Bao; Song Wang; Kaijin Lu
Journal:  Oncol Lett       Date:  2017-10-31       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.